Income Statement Precision System Science Co., Ltd.

Stocks

7707

JP3833400009

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange 12:00:00 04/09/2026 pm IST			5-day change	1st Jan Change
212.00 ^JPY	+2.91%		-3.20%	+13.98%

07/25/07	Tranche Update on Precision System Science Co., Ltd.'s Equity Buyback Plan announced on March 6, 2025.	CI
07/25/07	Precision System Science Co., Ltd.'s Equity Buyback announced on March 6, 2025 has closed with 440,600 shares, representing 1.59% for ¥100.46 million.	CI

fbe6243d06e7d1f7.z0PLd8IDhq3Dei6mP1P2dn4LhuyoS9gZbl6_0oxgOgs.kCCHQJ1Ow52QLErfCBivMhVF9YmdGO1KIzb0kNxWD32_Cf0cknTq6YAQdw

Published financial data: PRECISION SYSTEM SCIENCE CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Revenues	929.8Cr	743.4Cr	527.8Cr	397.9Cr	469.2Cr
Total Revenues	929.8Cr	743.4Cr	527.8Cr	397.9Cr	469.2Cr
Cost of Goods Sold, Total	620.1Cr	494.7Cr	392.8Cr	303Cr	331.2Cr
Gross Profit	309.7Cr	248.7Cr	135Cr	95Cr	138Cr
Selling General & Admin Expenses, Total	165.1Cr	194.4Cr	209.3Cr	169Cr	137.4Cr
Provision for Bad Debts	-	50L	-60L	-	-
R&D Expenses	55Cr	38Cr	38Cr	22Cr	13Cr
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	220.2Cr	233.4Cr	246.2Cr	190.6Cr	150.2Cr
Operating Income	90Cr	15Cr	-111.2Cr	-96Cr	-12Cr
Interest Expense, Total	-1.6Cr	-3.8Cr	-4Cr	-3.1Cr	-2Cr
Interest And Investment Income	10L	-	20L	10L	20L
Net Interest Expenses	-1.5Cr	-3.8Cr	-3.8Cr	-3Cr	-1.8Cr
Income (Loss) On Equity Invest.	-	-	-30L	-2.6Cr	-50L
Currency Exchange Gains (Loss)	40L	6.4Cr	1.6Cr	50L	-30L
Other Non Operating Income (Expenses)	-11Cr	-30L	-50L	-20L	80L
EBT, Excl. Unusual Items	77Cr	18Cr	-114.2Cr	-101Cr	-14Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	80L
Gain (Loss) On Sale Of Assets	-	-	-	-30L	-10L
Asset Writedown	-	-90L	-7.8Cr	-161.8Cr	-40L
Legal Settlements	-	-	-	-	-5.4Cr
Other Unusual Items	-	-	-5.6Cr	152.9Cr	-5.8Cr
EBT, Incl. Unusual Items	77Cr	17Cr	-127.6Cr	-110.2Cr	-25Cr
Income Tax Expense	-2.5Cr	12Cr	4.8Cr	1.9Cr	40L
Earnings From Continuing Operations	80Cr	4.5Cr	-132.4Cr	-112.1Cr	-25Cr
Net Income to Company	80Cr	4.5Cr	-132.4Cr	-112.1Cr	-25Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	80Cr	4.5Cr	-132.4Cr	-112.1Cr	-25Cr
Net Income to Common Incl Extra Items	80Cr	4.5Cr	-132.4Cr	-112.1Cr	-25Cr
Net Income to Common Excl. Extra Items	80Cr	4.5Cr	-132.4Cr	-112.1Cr	-25Cr
Per Share Items
Net EPS - Basic	29.21	1.63	-47.92	-40.57	-9.2
Basic EPS - Continuing Operations	29.21	1.63	-47.92	-40.57	-9.2
Basic Weighted Average Shares Outstanding	2.72Cr	2.76Cr	2.76Cr	2.76Cr	2.75Cr
Net EPS - Diluted	29.1	1.63	-47.92	-40.57	-9.2
Diluted EPS - Continuing Operations	29.1	1.63	-47.92	-40.57	-9.2
Diluted Weighted Average Shares Outstanding	2.73Cr	2.76Cr	2.76Cr	2.76Cr	2.75Cr
Normalized Basic EPS	17.68	3.98	-25.83	-22.85	-3.18
Normalized Diluted EPS	17.6	3.98	-25.83	-22.85	-3.18
Dividend Per Share	5	-	-	-	-
Payout Ratio	-	306.67	-	-	-
Supplemental Items
EBITDA	126.8Cr	69Cr	-47Cr	-55Cr	12Cr
EBITA	90Cr	15Cr	-111.2Cr	-96Cr	-12Cr
EBIT	90Cr	15Cr	-111.2Cr	-96Cr	-12Cr
Effective Tax Rate - (Ratio)	-3.25	73.05	-3.76	-1.72	-1.61
Normalized Net Income	48Cr	11Cr	-71Cr	-63Cr	-8.75Cr
Non-Cash Pension Expense	2.7Cr	3Cr	3Cr	3Cr	2.6Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	55Cr	38Cr	38Cr	22Cr	13Cr

Fiscal Period: June	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Assets
Cash And Equivalents	403.9Cr	276.3Cr	244.6Cr	191.5Cr	103.6Cr
Total Cash And Short Term Investments	403.9Cr	276.3Cr	244.6Cr	191.5Cr	103.6Cr
Accounts Receivable, Total	193Cr	168.5Cr	81Cr	65Cr	67Cr
Other Receivables	66Cr	50Cr	27Cr	22Cr	6.8Cr
Total Receivables	259Cr	218.4Cr	108.1Cr	87Cr	74Cr
Inventory	217.8Cr	183.1Cr	214.4Cr	169.4Cr	150.2Cr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	12Cr	21Cr	20Cr	13Cr	9.3Cr
Total Current Assets	892.5Cr	698.9Cr	587.1Cr	460.9Cr	336.6Cr
Net Property Plant And Equipment	229.4Cr	383.1Cr	337.4Cr	158Cr	144.4Cr
Long-term Investments	5.8Cr	13Cr	16Cr	6.7Cr	4.2Cr
Other Intangibles, Total	16Cr	42Cr	34Cr	14Cr	8.3Cr
Deferred Tax Assets Long-Term	13Cr	4.1Cr	1.1Cr	-	-
Other Long-Term Assets, Total	10L	20L	20L	20L	20L
Total Assets	1.16TCr	1.14TCr	976.1Cr	639.6Cr	493.7Cr
Liabilities
Accounts Payable, Total	75Cr	40Cr	30Cr	38Cr	35Cr
Accrued Expenses, Total	7.4Cr	6.3Cr	4.5Cr	4.4Cr	5.4Cr
Short-term Borrowings	220Cr	110Cr	80Cr	80Cr	50Cr
Current Portion of Long-Term Debt	20Cr	25Cr	54Cr	28Cr	3.4Cr
Current Income Taxes Payable	11Cr	2.5Cr	2.5Cr	1.2Cr	1Cr
Other Current Liabilities	36Cr	38Cr	30Cr	44Cr	20Cr
Total Current Liabilities	369.9Cr	221.7Cr	200.6Cr	195.8Cr	114.6Cr
Long-Term Debt	128.4Cr	267.2Cr	252.2Cr	29Cr	3Cr
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	30L	10L	-
Other Non Current Liabilities	70L	1Cr	90L	60L	20L
Total Liabilities	499Cr	489.9Cr	454Cr	225.4Cr	117.8Cr
Common Stock, Total	464.3Cr	464.3Cr	464.3Cr	10Cr	10Cr
Additional Paid In Capital	255.1Cr	115.4Cr	115.4Cr	569.7Cr	569.7Cr
Retained Earnings	-57Cr	73Cr	-59Cr	-171.4Cr	-196.7Cr
Treasury Stock	-	-2.3Cr	-2.3Cr	-2.3Cr	-12Cr
Comprehensive Income and Other	-4.9Cr	60L	3.9Cr	8.2Cr	5.2Cr
Total Common Equity	657.8Cr	651.1Cr	522.1Cr	414.2Cr	375.9Cr
Minority Interest	-	-	-	-	-
Total Equity	657.8Cr	651.1Cr	522.1Cr	414.2Cr	375.9Cr
Total Liabilities And Equity	1.16TCr	1.14TCr	976.1Cr	639.6Cr	493.7Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.77Cr	2.76Cr	2.76Cr	2.76Cr	2.72Cr
ECS Total Common Shares Outstanding	2.77Cr	2.76Cr	2.76Cr	2.76Cr	2.72Cr
Book Value / Share	237.76	235.64	188.95	149.9	138.25
Tangible Book Value	641.7Cr	609.2Cr	487.7Cr	400.4Cr	367.6Cr
Tangible Book Value Per Share	231.94	220.47	176.5	144.91	135.19
Total Debt	368.6Cr	401.9Cr	386.6Cr	136.5Cr	56Cr
Net Debt	-35Cr	125.6Cr	142Cr	-55Cr	-47Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Inventories - Raw Materials, Total	113.7Cr	90Cr	89Cr	91Cr	85Cr
Inventories - Work In Process, Total	16Cr	11Cr	7.1Cr	3.9Cr	4.2Cr
Inventories - Finished Goods, Total	87Cr	82Cr	118.6Cr	74Cr	61Cr
Inventories - Others	20L	10L	10L	10L	10L
Full Time Employees	187	196	199	158	151
Accumulated Allowance for Doubtful Accounts (Supple)	20L	70L	10L	-	10L
Order Backlog	100Cr	75Cr	136.24Cr	213.16Cr	123.11Cr

Fiscal Period: June	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Net Income	77Cr	17Cr	-127.5Cr	-110.2Cr	-25Cr
Depreciation & Amortization - CF	37Cr	53Cr	64Cr	41Cr	24Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	37Cr	53Cr	64Cr	41Cr	24Cr
(Gain) Loss From Sale Of Asset	-	80L	7.9Cr	162.1Cr	50L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-80L
(Income) Loss On Equity Investments - (CF)	-	-	30L	2.6Cr	50L
Other Operating Activities, Total	-2.3Cr	-14Cr	-6Cr	-3.3Cr	-19Cr
Change In Accounts Receivable	-36Cr	25Cr	89Cr	18Cr	-2.8Cr
Change In Inventories	-97Cr	21Cr	-35Cr	25Cr	19Cr
Change In Accounts Payable	13Cr	-35Cr	-11Cr	3.4Cr	1.7Cr
Change in Other Net Operating Assets	-20Cr	19Cr	18Cr	-148.3Cr	11Cr
Cash from Operations	-28Cr	87Cr	-60L	-11Cr	9.5Cr
Capital Expenditure	-166.6Cr	-195.6Cr	-14Cr	-1.2Cr	-5.3Cr
Sale of Property, Plant, and Equipment	-	20L	-	2Cr	-
Divestitures	-	-	-	-	1.8Cr
Sale (Purchase) of Intangible assets	-14Cr	-29Cr	-2Cr	-1.1Cr	-
Investment in Marketable and Equity Securities, Total	-	-	-5.1Cr	-	2Cr
Other Investing Activities, Total	-10L	-3.9Cr	-70L	205.9Cr	70L
Cash from Investing	-181.2Cr	-228.5Cr	-21Cr	205.6Cr	-80L
Short Term Debt Issued, Total	170Cr	-	-	-	-
Long-Term Debt Issued, Total	119.8Cr	173.9Cr	60Cr	-	-
Total Debt Issued	289.8Cr	173.9Cr	60Cr	-	-
Short Term Debt Repaid, Total	-	-110Cr	-30Cr	-	-30Cr
Long-Term Debt Repaid, Total	-22Cr	-31Cr	-45Cr	-249.9Cr	-50Cr
Total Debt Repaid	-22Cr	-140.7Cr	-75Cr	-249.9Cr	-80Cr
Issuance of Common Stock	143.7Cr	-	-	-	-
Repurchase of Common Stock	-	-9.9Cr	-	-	-10Cr
Common Dividends Paid	-	-14Cr	-	-	-
Common & Preferred Stock Dividends Paid	-	-14Cr	-	-	-
Other Financing Activities, Total	-11Cr	-20L	-10L	-90L	-80L
Cash from Financing	400.2Cr	9.3Cr	-15Cr	-250.8Cr	-91Cr
Foreign Exchange Rate Adjustments	1.7Cr	4.6Cr	5.7Cr	2.7Cr	-3.5Cr
Miscellaneous Cash Flow Adjustments	-20L	20L	-10L	-	-
Net Change in Cash	192.5Cr	-127.5Cr	-32Cr	-53Cr	-86Cr
Supplemental Items
Cash Interest Paid	1.7Cr	3.7Cr	4Cr	3Cr	2Cr
Cash Income Tax Paid (Refund)	2.2Cr	14Cr	40L	-60L	80L
Levered Free Cash Flow	-241.66Cr	-140.91Cr	36Cr	72Cr	19Cr
Unlevered Free Cash Flow	-240.66Cr	-138.54Cr	38Cr	74Cr	20Cr
Change In Net Working Capital	152.8Cr	-23Cr	-59Cr	-95Cr	-9.4Cr
Net Debt Issued / Repaid	267.3Cr	33Cr	-15Cr	-249.9Cr	-80Cr

Fiscal Period: June	2021 (JPY)	2022 (JPY)	2023 (JPY)	2024 (JPY)	2025 (JPY)
Profitability
Return on Assets	6.21	0.83	-6.57	-7.4	-1.35
Return on Total Capital	7.17	0.92	-7.09	-8.2	-1.55
Return On Equity %	14.59	0.69	-22.57	-23.95	-6.4
Return on Common Equity	14.59	0.69	-22.57	-23.95	-6.4
Margin Analysis
Gross Profit Margin %	33.31	33.45	25.58	23.85	29.41
SG&A Margin	17.76	26.15	39.66	42.47	29.28
EBITDA Margin %	13.64	9.24	-8.92	-13.77	2.47
EBITA Margin %	9.63	2.06	-21.07	-24.05	-2.6
EBIT Margin %	9.63	2.06	-21.07	-24.05	-2.6
Income From Continuing Operations Margin %	8.55	0.61	-25.09	-28.17	-5.39
Net Income Margin %	8.55	0.61	-25.09	-28.17	-5.39
Net Avail. For Common Margin %	8.55	0.61	-25.09	-28.17	-5.39
Normalized Net Income Margin	5.18	1.48	-13.52	-15.86	-1.86
Levered Free Cash Flow Margin	-25.99	-18.96	6.8	18.08	4.05
Unlevered Free Cash Flow Margin	-25.88	-18.64	7.28	18.57	4.32
Asset Turnover
Asset Turnover	1.03	0.65	0.5	0.49	0.83
Fixed Assets Turnover	5.53	2.43	1.47	1.61	3.1
Receivables Turnover (Average Receivables)	5.31	4.11	4.23	5.46	7.13
Inventory Turnover (Average Inventory)	3.62	2.47	1.98	1.58	2.07
Short Term Liquidity
Current Ratio	2.41	3.15	2.93	2.35	2.94
Quick Ratio	1.79	2.23	1.76	1.42	1.55
Operating Cash Flow to Current Liabilities	-0.08	0.39	-0	-0.05	0.08
Days Sales Outstanding (Average Receivables)	68.72	88.75	86.2	67.06	51.23
Days Outstanding Inventory (Average Inventory)	100.92	147.9	184.68	231.8	176.11
Average Days Payable Outstanding	35.23	45.86	30.12	48.02	42.64
Cash Conversion Cycle (Average Days)	134.41	190.78	240.76	250.84	184.69
Long Term Solvency
Total Debt/Equity	56.04	61.73	74.05	32.96	15
Total Debt / Total Capital	35.91	38.17	42.54	24.79	13.05
LT Debt/Equity	19.52	41.04	48.3	6.98	0.8
Long-Term Debt / Total Capital	12.51	25.38	27.75	5.25	0.69
Total Liabilities / Total Assets	43.14	42.94	46.51	35.24	23.86
EBIT / Interest Expense	55.94	4.03	-27.8	-30.87	-6.1
EBITDA / Interest Expense	79.25	18.08	-11.78	-17.68	5.8
(EBITDA - Capex) / Interest Expense	-24.88	-33.39	-15.15	-18.06	3.15
Total Debt / EBITDA	2.91	5.85	-8.21	-2.49	4.86
Net Debt / EBITDA	-0.28	1.83	-3.01	1	-4.07
Total Debt / (EBITDA - Capex)	-9.26	-3.17	-6.38	-2.44	8.95
Net Debt / (EBITDA - Capex)	0.89	-0.99	-2.34	0.98	-7.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	83.5	-20.05	-29	-24.61	17.92
Gross Profit, 1 Yr. Growth %	98.91	-19.7	-45.72	-29.7	45.42
EBITDA, 1 Yr. Growth %	3.15T	-45.82	-168.56	16.35	-121.17
EBITA, 1 Yr. Growth %	-1.19T	-82.91	-826.8	-13.94	-87.25
EBIT, 1 Yr. Growth %	-1.19T	-82.91	-826.8	-13.94	-87.25
Earnings From Cont. Operations, 1 Yr. Growth %	-797.37	-94.34	-3.04T	-15.33	-77.43
Net Income, 1 Yr. Growth %	-797.37	-94.34	-3.04T	-15.33	-77.43
Normalized Net Income, 1 Yr. Growth %	-936.96	-77.14	-748.86	-11.56	-86.14
Diluted EPS Before Extra, 1 Yr. Growth %	-761.58	-94.4	-3.04T	-15.33	-77.32
Accounts Receivable, 1 Yr. Growth %	22.85	-12.69	-52.05	-19.55	2.62
Inventory, 1 Yr. Growth %	74.1	-15.93	17.09	-20.99	-11.33
Net Property, Plant and Equip., 1 Yr. Growth %	115	67	-11.93	-53.17	-8.61
Total Assets, 1 Yr. Growth %	79.74	-1.37	-14.45	-34.47	-22.81
Tangible Book Value, 1 Yr. Growth %	49.37	-5.06	-19.94	-17.9	-8.19
Common Equity, 1 Yr. Growth %	52.27	-1.02	-19.81	-20.67	-9.25
Cash From Operations, 1 Yr. Growth %	1.23T	-410.36	-100.69	1.67T	-189.62
Capital Expenditures, 1 Yr. Growth %	697.13	17.41	-93.1	-91.11	341.67
Levered Free Cash Flow, 1 Yr. Growth %	-3.62T	-41.69	-125.48	100.42	-73.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-3.36T	-42.44	-127.72	92.42	-72.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	45.68	21.13	-24.66	-26.84	-5.71
Gross Profit, 2 Yr. CAGR %	41.31	26.38	-33.98	-38.23	1.1
EBITDA, 2 Yr. CAGR %	125.66	319.71	-39.05	-10.69	-50.37
EBITA, 2 Yr. CAGR %	133.61	36.6	11.47	150.1	-66.88
EBIT, 2 Yr. CAGR %	133.61	36.6	11.47	150.1	-66.88
Earnings From Cont. Operations, 2 Yr. CAGR %	147.29	-37.17	29.05	399.11	-56.29
Net Income, 2 Yr. CAGR %	147.29	-37.17	29.05	399.11	-56.29
Normalized Net Income, 2 Yr. CAGR %	136.21	38.31	21.78	139.55	-64.99
Diluted EPS Before Extra, 2 Yr. CAGR %	134.1	-39.15	28.32	399.13	-56.18
Accounts Receivable, 2 Yr. CAGR %	26.87	3.56	-35.3	-37.89	-9.14
Inventory, 2 Yr. CAGR %	24.24	20.98	-0.78	-3.81	-16.3
Net Property, Plant and Equip., 2 Yr. CAGR %	76.07	89.48	21.28	-35.78	-34.58
Total Assets, 2 Yr. CAGR %	44.97	33.15	-8.14	-25.13	-28.88
Tangible Book Value, 2 Yr. CAGR %	27.09	19.08	-12.82	-18.93	-13.18
Common Equity, 2 Yr. CAGR %	28.62	22.77	-10.91	-20.24	-15.15
Cash From Operations, 2 Yr. CAGR %	-16.65	543.28	-85.36	-65.07	297.91
Capital Expenditures, 2 Yr. CAGR %	332.66	205.92	-71.53	-92.17	-37.34
Levered Free Cash Flow, 2 Yr. CAGR %	130.18	352.73	-61.46	-28.54	-27.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	131.13	333.41	-60.06	-26.97	-27.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	36.69	19.28	1.37	-24.64	-14.22
Gross Profit, 3 Yr. CAGR %	33.15	17.05	-4.64	-32.58	-17.83
EBITDA, 3 Yr. CAGR %	61.33	40.26	129.43	-24.39	-44.73
EBITA, 3 Yr. CAGR %	32.47	-2.29	138.47	2.26	-7.27
EBIT, 3 Yr. CAGR %	32.47	-2.29	138.47	2.26	-7.27
Earnings From Cont. Operations, 3 Yr. CAGR %	20.27	-29.79	126.46	12.14	77.82
Net Income, 3 Yr. CAGR %	20.27	-29.79	126.46	12.14	77.82
Normalized Net Income, 3 Yr. CAGR %	25.67	8.45	131.54	9.47	-7.34
Diluted EPS Before Extra, 3 Yr. CAGR %	13.67	-32.56	121.68	11.71	78.12
Accounts Receivable, 3 Yr. CAGR %	27.55	12.01	-19.88	-30.43	-26.58
Inventory, 3 Yr. CAGR %	22.25	9.07	19.67	-8.04	-6.39
Net Property, Plant and Equip., 3 Yr. CAGR %	48.54	72.99	46.78	-11.69	-27.76
Total Assets, 3 Yr. CAGR %	31.15	27.51	14.89	-17.92	-24.36
Tangible Book Value, 3 Yr. CAGR %	24.93	15.31	4.32	-14.55	-15.5
Common Equity, 3 Yr. CAGR %	25.95	17.87	6.52	-14.29	-16.73
Cash From Operations, 3 Yr. CAGR %	106.06	29.19	-34.14	-27.66	-52.18
Capital Expenditures, 3 Yr. CAGR %	148.93	180.11	-13.56	-80.69	-69.96
Levered Free Cash Flow, 3 Yr. CAGR %	817.88	45.64	73.49	-33.23	-48.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	719.36	45.42	73.32	-32.54	-47.3
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.84	14.08	7.71	-1.91	-1.53
Gross Profit, 5 Yr. CAGR %	17.24	13.06	0.57	-9.36	-2.38
EBITDA, 5 Yr. CAGR %	23.24	15.38	9.3	17.09	24.36
EBITA, 5 Yr. CAGR %	4.1	-19.04	23.63	42.3	8.27
EBIT, 5 Yr. CAGR %	3.93	-19.04	23.63	42.3	8.27
Earnings From Cont. Operations, 5 Yr. CAGR %	-14.71	-39.5	23.71	53.86	17.29
Net Income, 5 Yr. CAGR %	-12.86	-39.5	23.71	53.86	17.29
Normalized Net Income, 5 Yr. CAGR %	7.57	-16.28	24.1	48.9	8.76
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.96	-42.75	19.32	50.18	15.91
Accounts Receivable, 5 Yr. CAGR %	14.03	15.49	-2.77	-11.53	-15.75
Inventory, 5 Yr. CAGR %	13.6	4.79	12.46	3.72	3.72
Net Property, Plant and Equip., 5 Yr. CAGR %	26.51	40.13	36.96	16.38	6.24
Total Assets, 5 Yr. CAGR %	14.73	14.48	13.74	3.05	-5.16
Tangible Book Value, 5 Yr. CAGR %	13.61	10.2	8.18	0.16	-3.07
Common Equity, 5 Yr. CAGR %	14.17	11.66	9.66	0.82	-2.74
Cash From Operations, 5 Yr. CAGR %	31.21	1.62	-28.45	-23.44	35.24
Capital Expenditures, 5 Yr. CAGR %	44.33	50.07	4.56	-33.02	-24
Levered Free Cash Flow, 5 Yr. CAGR %	48.38	9.16	158.26	9.54	22.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	47.5	8.99	144.72	10.4	22.42